Research: Anticoagulant Use and Risk of Ischemic Stroke and Bleeding in Patients With Secondary Atrial Fibrillation

Anticoagulant Use and Risk of Ischemic Stroke and Bleeding in Patients With Secondary Atrial Fibrillation Associated With Acute Coronary Syndromes, Acute Pulmonary Disease, or Sepsis – JACC: Clinical Electrophysiology (link to abstract – $ for full-text)

Commentaries: Anticoagulation didn’t benefit patients with afib secondary to ACS, pulmonary disease, or sepsis – ACP Hospitalist (free) AND No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib – TCTMD (free)